Kala Subramanian
Overview
Kala Subramanian received $2M in total compensation, including $180K in salary, at CRISPR Therapeutics AG in 2016.
Source: SEC filing on April 18, 2017.
Related executives
We found eight more executives who work or worked at CRISPR Therapeutics AG.
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
Lawrence Klein
CRISPR Therapeutics AG
Chief Operating Officer
James Kasinger
CRISPR Therapeutics AG
General Counsel
Michael Tomsicek
CRISPR Therapeutics AG
Chief Financial Officer
Rodger Novak
CRISPR Therapeutics AG
President
Marc Becker
CRISPR Therapeutics AG